EUDA Health Faces Nasdaq $35M Market-Value Deficiency, 180-Day Deadline
EUDA Health failed to maintain a $35 million minimum market value of listed securities over 32 consecutive business days under Nasdaq rules. Nasdaq has given a 180-day compliance window until October 20, 2026 to regain compliance by closing above $35 million market value for ten consecutive days or face delisting.
1. Nasdaq Listing Deficiency Notice
On April 23, 2026, EUDA Health received a written notice from Nasdaq’s Listing Qualifications Department stating the company failed to maintain a Minimum Market Value of Listed Securities of $35 million over 32 consecutive business days in violation of Listing Rule 5550(b)(2).
2. Compliance Requirements and Timeline
Nasdaq has provided a 180-calendar-day period through October 20, 2026 for EUDA to restore a closing market value of at least $35 million for ten consecutive business days to regain compliance.
3. Delisting Risks and Appeal Process
Failure to meet the market-value requirement by the deadline will prompt Nasdaq to issue a delisting notice, though EUDA may file an appeal to contest the determination without any assurance of continued listing.
4. Company Overview
EUDA Health is a Singapore-based non-invasive healthcare provider serving markets in Singapore, Malaysia and China, aiming to lead the regional longevity sector and manage property assets in Singapore.